UChicago Medicine Comprehensive Cancer Center has appointed Mitchell Posner, MD, as chief clinical officer. He will also serve as CCO for the health system's cancer service line.
Author: Elizabeth Gregerson
Oncologists are praising the surgeon general's recommendation to add cancer-risk warning labels to alcohol.
Stanford (Calif.) Medicine researchers have trained an AI model to analyze medical imaging data alongside pathology reports to accurately predict cancer prognoses and outcomes, according to a study published Jan. 8 in Nature.
When physician Claire Raab, MD, sat down to read the latest cancer catchment data from Fox Chase Cancer Center in Philadelphia, she was floored.
Iowa City-based University of Iowa Health Care has acquired Mission Cancer + Blood, a physician-owned oncology practice with more than 20 cancer clinics across the state.
Baltimore-based Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Washington, D.C.-based Howard University Cancer Center are "reigniting" their established partnership to eliminate health disparities in the Washington, D.C., area.
A topical immunotherapy drug can effectively eliminate precancerous spots, preventing squamous cell carcinoma occurrence, according to a study published Jan. 2 in the Journal of Clinical Investigation.
Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.
The Grand Rapids, Mich.-based Van Andel Institute has developed a new free and publicly available resource for identifying and classifying cancer subtypes.
Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature.
